Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panblok H7N9 vaccine in healthy adults
NCT02464163Phase 2Completed
- Sponsor
- Protein Sciences
- Start
- Jul 2015
- Primary completion
- Aug 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Panblok in avian influenza A(H7N9) infection (H7N9), sponsored by Protein Sciences. Started Jul 2015; status: completed.
02
Drugs
Panblok
03
Conditions
avian influenza A(H7N9) infection (H7N9)
Beyond the preview
Go deeper on NCT02464163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02464163.